The novelties of the regulation on health technology assessment, a key achievement for the European union health policies
-
and
Abstract
Health technology assessment is a key tool for ensuring healthcare quality, accessibility, and sustainability. The novel European Union (EU) Health Technology Assessment (HTA) regulation of 15 December 2021, in harmonizing the laws of the Member States about the procedures and criteria for the evaluation of health technologies (i.e., medical devices and in vitro diagnostic tools), constitutes a significant achievement in the definition of EU health policies. On the one hand, for the European Union, it constitutes an essential driving force for the development of a competitive market for health technologies and, on the other, for European citizens, it guarantees the application of superordinate safety and quality standards with an impact positive on access to health technologies, including expressly also in vitro diagnostic medical devices classified in class D by art. 47 of Reg. (EU) 2017/746. As pointed out by the European Commissioner for Healthcare, the regulation identifies a new way for the Member States to cooperate on healthcare matters in the Union. The clinical efficacy and safety of drugs and devices are legal assets that today find their protection in a binding and directly applicable regulatory instrument, superordinate in the hierarchy of sources. Implementing the regulation will also be essential to achieve the objectives of the Union’s pharmaceutical strategy and the European plan to fight cancer. The novel HTA European regulation, applicable from January 2025, will ensure inclusion and transparency in evaluating health technologies and increase the predictability of decisions for both Member State authorities and industry.
-
Research funding: None declared.
-
Author contributions: G.B. devised the manuscript; A.P. drew up the manuscript; G.B. and R.T examined the manuscript critically for important intellectual content. All authors have approved the final version to be published. All authors are responsible for all aspects of the work in ensuring that matters relating to the accuracy or integrity of any part of the work is properly researched and resolved.
-
Competing interests: Authors state no conflict of interest.
-
Informed consent: Not applicable.
-
Ethical approval: Not applicable.
References
1. Luhnen, M, Ormstad, SS, Willemsen, A, Schreuder-Morel, C, Helmink, C, Ettinger, S, et al.. Developing a quality management system for the European network for health technology assessment (EUnetHTA): toward European HTA collaboration. Int J Technol Assess Health Care 2021;37:e59. https://doi.org/10.1017/s0266462321000313.Search in Google Scholar PubMed
2. Website of the European Union. Available from https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=uriserv%3AOJ.L_.2021.458.01.0001.01.ENG&toc=OJ%3AL%3A2021%3A458%3AFULL [Accessed 9 May 2022].Search in Google Scholar
3. Website of the European Union. Available from https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=COM%3A2015%3A550%3AFIN [Accessed 9 May 2022].Search in Google Scholar
4. Website of the European Union. Available from https://ec.europa.eu/commission/presscorner/detail/en/qanda_21_6773 [Accessed 9 May 2022].Search in Google Scholar
5. Website of the European Union. Available from https://ec.europa.eu/health/system/files/2018-02/2018_ia_final_en_0.pdf [Accessed 9 May 2022].Search in Google Scholar
6. Plebani, M. Laboratory medicine in the COVID-19 era: six lessons for the future. Clin Chem Lab Med 2021;59:1035–45. https://doi.org/10.1515/cclm-2021-0367.Search in Google Scholar PubMed
7. Tomaiuolo, R, Derrico, P, Ritrovato, M, Locatelli, M, Milella, F, Restelli, U, et al.. COVIDIAGNOSTIX: health technology assessment of serological tests for SARS-CoV-2 infection. Int J Technol Assess Health Care 2021;37:e87. https://doi.org/10.1017/s0266462321000441.Search in Google Scholar PubMed
8. Website of the European Union. Available from https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=OJ:C:2014:438:FULL&from=NL [Accessed 9 May 2022].Search in Google Scholar
9. Campbell, CA, Horvath, AR. Harmonization of critical result management in laboratory medicine. Clin Chim Acta 2014;432:135–47. https://doi.org/10.1016/j.cca.2013.11.004.Search in Google Scholar PubMed
10. Ferraro, S, Biganzoli, EM, Castaldi, S, Plebani, M. Health Technology Assessment to assess the value of biomarkers in the decision-making process. Clin Chem Lab Med 2022;60:647–54. https://doi.org/10.1515/cclm-2021-1291.Search in Google Scholar PubMed
© 2022 Walter de Gruyter GmbH, Berlin/Boston
Articles in the same Issue
- Frontmatter
- Editorial
- Transdermal measurement of cardiac troponins: the future is now
- Reviews
- Perinatal presepsin assessment: a new sepsis diagnostic tool?
- Hypertriglyceridemia, a causal risk factor for atherosclerosis, and its laboratory assessment
- Opinion Paper
- The novelties of the regulation on health technology assessment, a key achievement for the European union health policies
- General Clinical Chemistry and Laboratory Medicine
- Performance of four regression frameworks with varying precision profiles in simulated reference material commutability assessment
- Comparison of six regression-based lot-to-lot verification approaches
- Failure Mode and Effects Analysis (FMEA) at the preanalytical phase for POCT blood gas analysis: proposal for a shared proactive risk analysis model
- Evaluation of a pneumatic tube system carrier prototype with fixing mechanism allowing for automated unloading
- Analytical performance of eight enzymatic assays for ethanol in serum evaluated by data from the Belgian external quality assessment scheme
- Vitamin D metabolism in living kidney donors before and after organ donation
- Validation of steroid ratios for random urine by mass spectrometry to detect 5α-reductase deficiency in Vietnamese children
- Evaluation of serum neurofilament light in the early management of mTBI patients
- Assessment of urine sample quality by the simultaneous measurement of urinary γ-glutamyltransferase and lactate dehydrogenase enzyme activities: possible application to unravel cheating in drugs of abuse testing
- Reference Values and Biological Variations
- Age and sex specific reference intervals of 13 hematological analytes in Chinese children and adolescents aged from 28 days up to 20 years: the PRINCE study
- Cancer Diagnostics
- Prostate health index (PHI) as a reliable biomarker for prostate cancer: a systematic review and meta-analysis
- A comparison of the faecal haemoglobin concentrations and diagnostic accuracy in patients suspected with colorectal cancer and serious bowel disease as reported on four different faecal immunochemical test systems
- Circulating cell-free DNA undergoes significant decline in yield after prolonged storage time in both plasma and purified form
- Cardiovascular Diseases
- Analytical and clinical performance evaluation of a new high-sensitivity cardiac troponin I assay
- Infectious Diseases
- Results of a SARS-CoV-2 virus genome detection external quality assessment round focusing on sensitivity of assays and pooling of samples
- Letters to the Editors
- Improving D-dimer testing appropriateness by controlling periodicity of retesting: prevention is better than cure
- Biological variation of serum cholinesterase catalytic concentrations
- Three-month ad interim analysis of total anti-SARS-CoV-2 antibodies in healthy recipient of a single BNT162b2 vaccine booster
- Fibrin strands in peripheral blood smear: the COVID-19 era
- Fragments of alpha-1-antitrypsin in patients with severe COVID-19 and bacterial pulmonary sepsis
- Comparison of thyroid stimulating hormone, free thyroxine, total triiodothyronine, thyroglobulin and peroxidase antibodies measurements by two different platforms
- Effect of different incubation times on the detection of factor VIII inhibitor in acquired hemophilia A
Articles in the same Issue
- Frontmatter
- Editorial
- Transdermal measurement of cardiac troponins: the future is now
- Reviews
- Perinatal presepsin assessment: a new sepsis diagnostic tool?
- Hypertriglyceridemia, a causal risk factor for atherosclerosis, and its laboratory assessment
- Opinion Paper
- The novelties of the regulation on health technology assessment, a key achievement for the European union health policies
- General Clinical Chemistry and Laboratory Medicine
- Performance of four regression frameworks with varying precision profiles in simulated reference material commutability assessment
- Comparison of six regression-based lot-to-lot verification approaches
- Failure Mode and Effects Analysis (FMEA) at the preanalytical phase for POCT blood gas analysis: proposal for a shared proactive risk analysis model
- Evaluation of a pneumatic tube system carrier prototype with fixing mechanism allowing for automated unloading
- Analytical performance of eight enzymatic assays for ethanol in serum evaluated by data from the Belgian external quality assessment scheme
- Vitamin D metabolism in living kidney donors before and after organ donation
- Validation of steroid ratios for random urine by mass spectrometry to detect 5α-reductase deficiency in Vietnamese children
- Evaluation of serum neurofilament light in the early management of mTBI patients
- Assessment of urine sample quality by the simultaneous measurement of urinary γ-glutamyltransferase and lactate dehydrogenase enzyme activities: possible application to unravel cheating in drugs of abuse testing
- Reference Values and Biological Variations
- Age and sex specific reference intervals of 13 hematological analytes in Chinese children and adolescents aged from 28 days up to 20 years: the PRINCE study
- Cancer Diagnostics
- Prostate health index (PHI) as a reliable biomarker for prostate cancer: a systematic review and meta-analysis
- A comparison of the faecal haemoglobin concentrations and diagnostic accuracy in patients suspected with colorectal cancer and serious bowel disease as reported on four different faecal immunochemical test systems
- Circulating cell-free DNA undergoes significant decline in yield after prolonged storage time in both plasma and purified form
- Cardiovascular Diseases
- Analytical and clinical performance evaluation of a new high-sensitivity cardiac troponin I assay
- Infectious Diseases
- Results of a SARS-CoV-2 virus genome detection external quality assessment round focusing on sensitivity of assays and pooling of samples
- Letters to the Editors
- Improving D-dimer testing appropriateness by controlling periodicity of retesting: prevention is better than cure
- Biological variation of serum cholinesterase catalytic concentrations
- Three-month ad interim analysis of total anti-SARS-CoV-2 antibodies in healthy recipient of a single BNT162b2 vaccine booster
- Fibrin strands in peripheral blood smear: the COVID-19 era
- Fragments of alpha-1-antitrypsin in patients with severe COVID-19 and bacterial pulmonary sepsis
- Comparison of thyroid stimulating hormone, free thyroxine, total triiodothyronine, thyroglobulin and peroxidase antibodies measurements by two different platforms
- Effect of different incubation times on the detection of factor VIII inhibitor in acquired hemophilia A
